Chemical Abstracts Service (CAS), a division of the American Chemical Society, has announced that India-based TCG Lifesciences Limited, a contract research services and informatics company, has signed a three-year contract to provide its scientists and researchers with unlimited access to SciFinder. SciFinder will help TCG Lifesciences grow its position as a contract research organisation that provides a new paradigm of cutting edge drug discovery and development platform in the competitive and fast growing Indian pharmaceutical research space.
The SciFinder research and discovery tool will offer TCG Lifesciences teams a variety of powerful research and analysis options, including Markush searching for retrieving additional patents for substances that are claimed in generic terms, and the recently-announced SciPlanner, an interactive reaction planning workspace especially valuable for pharmaceutical and biotechnology research.
SciFinder's comprehensive and current content, sophisticated analysis and collaboration capabilities, and demonstrated results inside the lab and out have made it the preferred source of chemical information for scientists around the globe. The application offers access to the CAS REGISTRYSM database, known as the gold standard of chemical substance collections. In addition, SciFinder claims to retrieve more references than any other scientific search service, including relevant patent documents, journal article information, and reliable web sources.
Search for more Research support tools
To access our daily STM news feed through your iPhone, iPad, or other smartphones, please visit www.myscoope.com for a mobile friendly reading experience.
